Cell therapies are among the most exciting advancements in oncology
Several CAR T-cell therapies have already been granted approval by the FDA and EMA, but the field is broadening. New therapies are tapping into stem cells, T-cell receptors (TCR), tumor-infiltrating lymphocytes, macrophages, and NK-cells to explore their therapeutic potential.
While these therapies can be more effective at targeting solid tumors, they face barriers throughout development.
Complex manufacturing processes
Rigorous regulatory expectations
Shortages of qualified staff and laboratories
Market access and commercialization challenges
Gain the insights needed to understand and overcome the unique clinical, translational, logistical, and manufacturing challenges associated with developing a novel cell therapy in this free ungated eBook.
Read first-hand insights from experts in oncology cell therapy
Within this resource, we go into detail on the current and future state of cell therapy development.
Environment: Current trends, in-depth breakdowns, and unrealized opportunities
Execution: Key nuances of cell therapy clinical trials, from therapeutic development, regulatory, and manufacturing considerations to site selection, lab partners, logistics, and data monitoring
Evolution: Ways to streamline insight generation that drive efficiency and propel cell therapy clinical trial execution forward
Rob Maiale is an award-winning creative director with over 15 years of experience developing content and marketing strategies for leading healthcare and pharmaceutical brands. His background spans patient education, clinical development, pharma, medical devices, and a broad range of diagnostic modalities. Rob partners with Precision experts to strategically showcase their knowledge through creative storytelling and engaging content strategies.